Patrick Donnelly
Stock Analyst at Citigroup
(3.87)
# 708
Out of 4,734 analysts
309
Total ratings
54.76%
Success rate
7.64%
Average return
Main Sectors:
Stocks Rated by Patrick Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Maintains: Buy | $300 → $290 | $205.07 | +41.42% | 8 | Jan 6, 2025 | |
| DHR Danaher | Maintains: Buy | $305 → $285 | $244.11 | +16.75% | 11 | Jan 6, 2025 | |
| FTRE Fortrea Holdings | Downgrades: Neutral | $30 → $23 | $18.70 | +22.99% | 4 | Dec 11, 2024 | |
| ILMN Illumina | Downgrades: Neutral | $190 → $165 | $141.31 | +16.76% | 14 | Dec 11, 2024 | |
| MTD Mettler-Toledo International | Upgrades: Neutral | $1,200 → $1,300 | $1,324.48 | -1.85% | 11 | Dec 11, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $44 → $50 | $43.72 | +14.36% | 4 | Dec 11, 2024 | |
| SHC Sotera Health Company | Maintains: Buy | $18 → $20 | $13.31 | +50.26% | 3 | Nov 6, 2024 | |
| BRKR Bruker | Maintains: Buy | $80 → $75 | $60.07 | +24.85% | 14 | Nov 6, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $80 → $75 | $54.26 | +38.22% | 13 | Nov 6, 2024 | |
| BIO.B Bio-Rad Laboratories | Maintains: Buy | $400 → $450 | $348.95 | +28.96% | 14 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $450 | $353.86 | +27.17% | 14 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $23 | $16.16 | +42.33% | 10 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $185 | $152.65 | +21.19% | 10 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $95 → $85 | $70.37 | +20.79% | 13 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $215 → $175 | $169.81 | +3.06% | 19 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $152.57 | +8.15% | 26 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $45 | $45.13 | -0.29% | 9 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $28 | $22.18 | +26.24% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $123.95 | +16.98% | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $23 | $21.77 | +5.65% | 7 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $85 | $78.75 | +7.94% | 10 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Neutral | $620 | $573.06 | +8.19% | 17 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $60 | $47.50 | +26.32% | 13 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $265 → $300 | $413.81 | -27.50% | 24 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $3.92 | +129.59% | 6 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $225 | $205.69 | +9.39% | 9 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.75 → $2.75 | $6.64 | -58.58% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $250 → $260 | $243.99 | +6.56% | 11 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $5.55 | +8.11% | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $28 → $32 | $12.57 | +154.57% | 2 | Nov 30, 2018 |
ICON Public Limited Company
Jan 6, 2025
Maintains: Buy
Price Target: $300 → $290
Current: $205.07
Upside: +41.42%
Danaher
Jan 6, 2025
Maintains: Buy
Price Target: $305 → $285
Current: $244.11
Upside: +16.75%
Fortrea Holdings
Dec 11, 2024
Downgrades: Neutral
Price Target: $30 → $23
Current: $18.70
Upside: +22.99%
Illumina
Dec 11, 2024
Downgrades: Neutral
Price Target: $190 → $165
Current: $141.31
Upside: +16.76%
Mettler-Toledo International
Dec 11, 2024
Upgrades: Neutral
Price Target: $1,200 → $1,300
Current: $1,324.48
Upside: -1.85%
QuidelOrtho
Dec 11, 2024
Upgrades: Buy
Price Target: $44 → $50
Current: $43.72
Upside: +14.36%
Sotera Health Company
Nov 6, 2024
Maintains: Buy
Price Target: $18 → $20
Current: $13.31
Upside: +50.26%
Bruker
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $60.07
Upside: +24.85%
Exact Sciences
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $54.26
Upside: +38.22%
Bio-Rad Laboratories
Oct 31, 2024
Maintains: Buy
Price Target: $400 → $450
Current: $348.95
Upside: +28.96%
Oct 31, 2024
Maintains: Buy
Price Target: $400 → $450
Current: $353.86
Upside: +27.17%
Oct 30, 2024
Maintains: Buy
Price Target: $35 → $23
Current: $16.16
Upside: +42.33%
Oct 23, 2024
Maintains: Buy
Price Target: $165 → $185
Current: $152.65
Upside: +21.19%
Oct 1, 2024
Downgrades: Neutral
Price Target: $95 → $85
Current: $70.37
Upside: +20.79%
Oct 1, 2024
Downgrades: Sell
Price Target: $215 → $175
Current: $169.81
Upside: +3.06%
Aug 22, 2024
Maintains: Buy
Price Target: $150 → $165
Current: $152.57
Upside: +8.15%
Aug 8, 2024
Maintains: Buy
Price Target: $40 → $45
Current: $45.13
Upside: -0.29%
Aug 7, 2024
Maintains: Buy
Price Target: $30 → $28
Current: $22.18
Upside: +26.24%
Jul 30, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $123.95
Upside: +16.98%
Jul 10, 2024
Downgrades: Neutral
Price Target: $30 → $23
Current: $21.77
Upside: +5.65%
May 22, 2024
Downgrades: Neutral
Price Target: $85
Current: $78.75
Upside: +7.94%
Mar 18, 2024
Reinstates: Neutral
Price Target: $620
Current: $573.06
Upside: +8.19%
Feb 8, 2024
Maintains: Buy
Price Target: $62 → $60
Current: $47.50
Upside: +26.32%
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $413.81
Upside: -27.50%
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $3.92
Upside: +129.59%
Dec 11, 2023
Maintains: Neutral
Price Target: $190 → $225
Current: $205.69
Upside: +9.39%
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $6.64
Upside: -58.58%
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $243.99
Upside: +6.56%
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $5.55
Upside: +8.11%
Nov 30, 2018
Upgrades: Neutral
Price Target: $28 → $32
Current: $12.57
Upside: +154.57%